For both sides

Dual license

Federal and state law current as of September 2026 — verify with counsel.

Key takeaways

  • Same operator holding medical and adult-use rights. Books must be apportioned for 280E after the 2026 split.
  • Use the term the way the regulator uses it.
  • Do not import another state’s definition.
  • Ask counsel before the LOI uses the word as a promise.

Dual license is the file this page underwrites. Same operator holding medical and adult-use rights. Books must be apportioned for 280E after the 2026 split. Federal and state law current as of September 2026 — verify with counsel. This is educational, not a guarantee of price, timing, approval, or financing.

Why Dual license matters in a cannabis sale — how should you read this on Dual license?

Owners lose months when Dual license is treated as slang. The application, the LOI, and the agency packet have to use one definition.

How Dual license is used correctly — what belongs on Dual license?

The correct use of Dual license is the one that a Massachusetts reviewer would recognize. Do not import a Washington habit unless the premises sit there.

How Dual license is misused — what belongs on Dual license?

The usual misuse is turning dual license into a premium without a citation. Buyers then treat it as optional. Neither side can close on that.

Use of Dual licenseBroker reading
Dual license in a CIMMust match the statute, not a slogan
Dual license in an LOIIf it requires agency consent, say so
Dual license in a modelLabel ranges; do not hide 280E
Dual license vs a neighbor wordDo not swap dual license for a look-alike term from another state

File example that turns on Dual license — what should you verify for Dual license?

Illustrative: a CIM inflates dual license into a premium. Diligence removes it. Price moves. See APA vs MIPA if the term changes who keeps the liability.

Nearby words people confuse with Dual license — why does this change Dual license?

If someone says dual license and means a different glossary entry, stop and pick the right slug. The glossary index exists so Dual license stays precise.

On Dual license, the federal overlay is a schedule split, not a national license. Federal Register 2026-08176 moved qualifying medical and FDA-approved marijuana to Schedule III on 28 April 2026. Adult-use marijuana stayed on Schedule I while a DEA hearing record sits with an administrative law judge. That is why IRC §280E still bites adult-use SG&A and why a medical slice can look different after tax.

Cited sources that govern Dual license: Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical.

Read 280E next if that file is open on Dual license. deal structure is the companion page when Dual license needs that angle. Keep sell in the working set for Dual license. Read buy next if that file is open on Dual license. 280E is the companion page when Dual license needs that angle. Keep METRC in the working set for Dual license. Read glossary index next if that file is open on Dual license. federal law is the companion page when Dual license needs that angle.

Which public sources belong on this file?

Cite FDA cannabis / CBD page, IRS marijuana industry page, eCFR CSA schedules, USDA hemp production. A forum post is not a substitute.

Frequently asked questions

What does Dual license mean in a cannabis sale?

Same operator holding medical and adult-use rights. Books must be apportioned for 280E after the 2026 split.

Is this legal advice?

No. Confirm the term against the statute and counsel.

Does the definition travel across states?

No. Dual license in one statute is not automatically Dual license in another.

Where does it show up in a deal?

Applications, LOIs, CIMs, and often the approval contingency.

Sources

  1. SBA SOP 50 10 8 (effective 1 June 2025) — marijuana ineligibility — https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs
  2. Congress.gov S.4942 — SAFE Banking Act of 2026 (introduced, not enacted) — https://www.congress.gov/bill/119th-congress/senate-bill/4942
  3. Congress.gov H.R.9471 — companion SAFE Banking bill — https://www.congress.gov/bill/119th-congress/house-bill/9471
  4. CRS IF13136 / IN12620 — hemp definition change effective 12 November 2026 (P.L. 119-37) — https://www.congress.gov/crs-product/IN12620
  5. IRC §280E — https://www.law.cornell.edu/uscode/text/26/280E
  6. FDA cannabis and CBD page — https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
  7. IRS marijuana industry — https://www.irs.gov/businesses/small-businesses-self-employed/marijuana-industry
  8. eCFR 21 CFR chapter II — https://www.ecfr.gov/current/title-21/chapter-II
  9. Federal Register 2026-08176 (28 April 2026) — medical / FDA-approved marijuana to Schedule III — https://www.federalregister.gov/d/2026-08176
  10. FinCEN FIN-2014-G001 — BSA expectations for marijuana-related businesses — https://www.fincen.gov/resources/statutes-regulations/guidance/bsa-expectations-regarding-marijuana-related-businesses
  11. Viridian Capital public commentary — Tier 1 U.S. MSO EV/EBITDA ~4.16x (2025 consensus)